Just reading the update again. Despite the restrictions imposed...

Just reading the update again. Despite the restrictions imposed by P&G regarding marketing there is clearly enough insight for OBJ to make the following statement:

-->Execution of the third and fourth Term Sheets for the licensing by our foremost partnering company of two new products containing the OBJ micro array technology. This brings to a total of four products under the Master Licensing Agreement for various skin applications and greatly expands the use of OBJ’s technology by volume.

Greatly expanded volume - I would like some more commentary from management on this, rather than perhaps saying that an extra 2 products means a 100% increase over the current two which is therefore a great expansion.

-->P&G has advised OBJ that the launch and rollout for the Wave II devices will commence in the third quarter of calendar 2017 and that the expected volumes have been increased.

P&G will be ordering product from the manufacturer in accordance with the increased expected sales volumes. Regardless of when they are sold, OBJ are paid based on the amount ordered.

They keywords - great expansion and increase in volume. Can OBJ provide more commentary regarding the expected volumes for products 2, 3 & 4?